Izote Biosciences reimagines solutions to the fermentation scale-up problem for the $24B bioprocess technology industry. We enable fermentation scale-up in the absence of oxygen, reducing CAPEX by 50%, OPEX by 36%, and overall raw material consumption. Izote Biosciences improves performance and process robustness compared to current aerobic fermentation processes and empowers users by adapting their existing workflows to our in-house production platforms. Izote Biosciences delivers a cost-effective solution to expeditiously develop and deploy the next generation of biomolecules and bioproducts. Izote Biosciences is at the forefront of the new oxygen-free bio-manufacturing era. We are engineering common production hosts (e.g. E. coli/Bacillus) with the ability to grow anaerobically. So both aerobic and anaerobic bugs will work with this technology. Also, since the metabolism produces some oxygen, manufacturing processes requiring oxygen should not be impacted.
Funding to Date